Future Medicinal Chemistry accepted for coverage by MEDLINE

NewsGuard 100/100 Score

Future Science Ltd announces today that its new journal Clinical Investigation which launched in January 2011 has been selected for coverage by Chemical Abstracts.

Chemical Abstracts, a division of the American Chemical Society, is the most authoritative and comprehensive source for chemical information. CAS databases, including CAS REGISTRYSM, the gold standard for substance information, are curated and quality-controlled by CAS scientists. Visit: www.cas.org to find out more.

Clinical Investigation is published monthly in print and online formats on a rapid publication basis, with articles subject to peer review by three independent assessors. The journal has an international expert authorship and provides a systematic program of peer-reviewed coverage relating to the clinical evaluation of new and established therapies.

Coverage of the journal is overseen by Senior Editor E. Michael Lewiecki, New Mexico Clinical Research & Osteoporosis Center, USA and an extensive international advisory panel.

Senior Editor Michael Lewiecki, commented: "Clinical Investigation fulfils an unmet need in providing critical review of the objectives and outcomes of clinical trials. I have no doubt that Clinical Investigation will become a go-to-source for timely and authoritative discussion regarding clinical research, its inclusion on Chemical Abstracts will greatly help broaden its appeal".

Elisa Manzotti, Editorial Director of the Future Science series commented, “We are delighted that Clinical Investigation has been accepted for inclusion and will work with the Senior Editors of the journal to ensure that future issues of the journal keep pace with the huge amount of research being generated.” Manzotti continued: “We would like to thank our Senior Editor and Editorial Board for their hard work, intellectual input and guidance in targeting and evaluating topical, pioneering content to ensure inclusion of the journal by Chemical Abstracts.

The first three issues of Clinical Investigation are FREE to access, if you would like to sample the journal, simply visit: www.future-science.com/loi/cli

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer